People: Athersys Inc (ATHX.OQ)

ATHX.OQ on NASDAQ Stock Exchange Capital Market

1.71USD
4:00pm EDT
Price Change (% chg)

$0.02 (+1.18%)
Prev Close
$1.69
Open
$1.69
Day's High
$1.78
Day's Low
$1.69
Volume
261,403
Avg. Vol
147,832
52-wk High
$4.33
52-wk Low
$1.09

Search Stocks

Harrington, John 

Brief Biography

Dr. John J. Harrington, Ph.D., is Executive Vice President, Chief Scientific Officer, Director of Athersys Inc. Dr. Harrington led the development of the RAGEĀ® technology, as well as its application for gene discovery, drug discovery and commercial protein production applications. He is a listed inventor on over 20 issued or pending United States patents, has authored numerous scientific publications, and has received numerous awards for his work, including being named one of the top international young scientists by MIT Technology Review in 2002. Dr. Harrington has overseen the therapeutic product development programs at Athersys since their inception, and is also focused on the clinical development and manufacturing of MultiStemĀ®. During his career, he has also held positions at Amgen and Scripps Clinic. He received his B.A. in Biochemistry and Cell Biology from the University of California at San Diego and his Ph.D. in Cancer Biology from Stanford University.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
434,916 -- 4,355 439,271

Options Compensation

  Quantity Market Value
Exercisable 717,892 --
Unexercisable 257,539 --
Exercised -- --
Name Fiscal Year Total

Gil Van Bokkelen

550,120

William Lehmann

440,522

John Harrington

439,271

Robert Deans

375,420

Laura Campbell

277,171

Manal Morsy

--
As Of 30 Dec 2013
Search Stocks